AbbVie
Fortune 1000 2013 #77 by revenue · ABBV United States Healthcare Pharmaceuticals abbvie.com
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products.
Fortune 1000's description, shown to identify the company. We rate the name, not the business.
- Evocativity EVOC : yellow
- French vie faintly suggests life to insiders
- Brevity BREV : green
- 6 letters, 2 syllables. Up to seven letters is green, eight at two syllables too; up to ten yellow, eleven or more red.
- Greppability GREP : green
- Found inside 0 other dictionary words.
- Googlability GOOG : green
- Distinctive coined whole
- Pronounceability PRON : yellow
- Ab-vee versus ab-vie is uncertain
- Spellability SPEL : red
- Double b and vie are not inferable by ear
- Verbability VERB : red
- No natural medicine action sense
- Nominology
- 65
- All seven dimensions and .com ownership, weighted as set out on Methodology.
- Fluency
- 70
- Brevity and pronounceability only: the subset with published outcome evidence behind it.
- PG grade
- 3 / 4
- Graham's own four-step ladder.
- Exact .com
- Owned
- Shape
- invented
- Length
- 6 chars, 2 syllables
- Distinctiveness
- suggestive
Watkins SCRATCH flags
- Curse-of-knowledge
- Spelling-challenged
This row is stitched from more than one source. Fortune 1000 supplied the company; forbes2000 filled year, country, and one_liner and S&P 500 / GICS filled subindustry.
Rubric version 2026.10.20-1, judged by gpt-6.1-sol (agent).
This scores the name only. See Methodology.
These judged dimensions came from an AI agent working through the judging queue in a chat, on the same rubric the scoring pipeline sends. The agent passed the calibration exam before its work was accepted, and each batch it judged hid two names with known answers as a check. The model is named as the agent reported it.